Artiva Biotherapeutics Inc (ARTV)
2.60 x 5 3.00 x 3
Post-market by (Cboe BZX)
2.86 -0.14 (-4.67%) 04/02/25 [NASDAQ]
2.60 x 5 3.00 x 3
Post-market 2.78 -0.08 (-2.80%) 16:02 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 251 | 33,492 |
| Gross Profit | 251 | 33,492 |
| Operating Expenses | 67,533 | 64,163 |
| Operating Income | -67,282 | -30,671 |
| Other Income | 1,909 | 2,023 |
| Pre-tax Income | -65,373 | -28,648 |
| Income Tax | N/A | 72 |
| Net Income Continuous | -65,373 | -28,720 |
| Net Income | $-65,373 | $-28,720 |
| EPS Basic Total Ops | -5.81 | -35.78 |
| EPS Basic Continuous Ops | -5.81 | -35.78 |
| EPS Diluted Total Ops | -5.81 | -35.78 |
| EPS Diluted Continuous Ops | -5.81 | -35.78 |
| EBITDA(a) | $-64,851 | $-28,405 |